Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard G Mather

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ Global Health|November 22, 2019
Redefining typhoid diagnosis: what would an improved test need to look like?Richard G Mather, Heidi Hopkins, Christopher M Parry, et al.
International Journal of Prison Health|June 18, 2024
COVID-19 in correctional facilities in Ontario, Canada: a retrospective epidemiological analysis from 15 January 2020 to 31 December 2022Austin Zygmunt, Kahiye Warsame, Richard G Mather, et al.
Emerging Infectious Diseases|September 25, 2024
Age- and Sex-Specific Differences in Lyme Disease Health-Related Behaviors, Ontario, Canada, 2015-2022Janica A Adams, Victoria Osasah, Katherine Paphitis, et al.
International Journal of Cancer|February 26, 2011
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agentsCarolyn A Goard, Richard G Mather, Balpreet Vinepal, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 31, 2025
Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024/25Lea Separovic, Yuping Zhan, Samantha E Kaweski, et al.
Influenza and Other Respiratory Viruses|March 5, 2026
Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID-19 in CanadaLea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2024
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)Danuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 11, 2024
Association between delayed outbreak identification and SARS-CoV-2 infection and mortality among long-term care home residents, Ontario, Canada, March to November 2020: a cohort studyKevin A Brown, Sarah A Buchan, Adrienne K Chan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulationDanuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 6, 2026
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026Lea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Global Health|November 22, 2019
Redefining typhoid diagnosis: what would an improved test need to look like?Richard G Mather, Heidi Hopkins, Christopher M Parry, et al.
International Journal of Prison Health|June 18, 2024
COVID-19 in correctional facilities in Ontario, Canada: a retrospective epidemiological analysis from 15 January 2020 to 31 December 2022Austin Zygmunt, Kahiye Warsame, Richard G Mather, et al.
Emerging Infectious Diseases|September 25, 2024
Age- and Sex-Specific Differences in Lyme Disease Health-Related Behaviors, Ontario, Canada, 2015-2022Janica A Adams, Victoria Osasah, Katherine Paphitis, et al.
International Journal of Cancer|February 26, 2011
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agentsCarolyn A Goard, Richard G Mather, Balpreet Vinepal, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 31, 2025
Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024/25Lea Separovic, Yuping Zhan, Samantha E Kaweski, et al.
Influenza and Other Respiratory Viruses|March 5, 2026
Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID-19 in CanadaLea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2024
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)Danuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 11, 2024
Association between delayed outbreak identification and SARS-CoV-2 infection and mortality among long-term care home residents, Ontario, Canada, March to November 2020: a cohort studyKevin A Brown, Sarah A Buchan, Adrienne K Chan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulationDanuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 6, 2026
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026Lea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Pageof 1